Advertisement
Document › Details
LifeArc. (8/30/17). "Press Release: LifeArc and AUTM Forge International Partnership to Provide Training for Scholars in Technology Transfer". London & Gainesville, FL.
Region | United Kingdom (GB) | |
Organisation | LifeArc (GB) | |
Organisation 2 | AUTM Foundation | |
Group | Association of University Technology Managers (AUTM) | |
Product | IP services | |
Product 2 | LIFE SCIENCES | |
Person | Farquharson, Andrew (MRC Technology 201507– Technology Transfer Director before AstraZeneca et al) | |
LifeArc, the medical research charity formerly known as MRC Technology, has partnered with The Association of University Technology Managers (AUTM) Foundation to offer a competitive program that will provide essential training for scientists seeking a career in life sciences technology transfer. This joint initiative emphasises the commitment of both organisations to improve access to the technology transfer profession.
“LifeArc’s generous funding and participation has made it possible for five UK scholars to gain a rich training experience provided through the AUTM Fellows program,” said Chris Yochim, Chairman of the AUTM Foundation. “Our collaboration supports the AUTM mission to advance academic technology transfer globally.”
The AUTM-LifeArc technology transfer program pairs UK life-science graduates and post-doctoral students with an experienced technology transfer mentor who will help them prepare for a career in technology transfer. Each successful Fellow has received a one-year AUTM membership with access to AUTM’s Technology Transfer Practice Manual (TTPM), which follows a core syllabus of educational webinars covering such topics as Basics of Technology Transfer, Invention Disclosures – From Cradle to Licensing, Basic Patenting, Marketing, and Negotiation. Fellows will also be funded to attend two major AUTM meetings in the US which draw 2,000 attendees from around the world, and offer over 80 educational sessions and significant networking opportunities.
“As a medical research charity, LifeArc works to identify, protect and manage promising scientific research so it can be developed into treatments and diagnostics for patients. By supporting the technology transfer professionals of the future we can increase our charitable impact as more science projects are effectively progressed,” said Andrew Farquharson, Executive Director, Technology Transfer at LifeArc.
Notes to editors
Media enquiries
For LifeArc
Katie Odgaard
Zyme Communications
E: Katie.odgaard@zymecommunications.com
T: +44 (0)7787 502 947
Liezel Tipper, PR & Communications Manager
LifeArc
E: Liezel.Tipper@lifearc.org
T: +44 (0) 20 7391 2772
For the AUTM Foundation
Kelly Markey
AUTM Foundation
E: kelly@autmfoundation.com
T: 352-256-6085
Further information
About LifeArc
LifeArc is a medical research and technology transfer charity with 25 years of experience helping scientists translate their innovations into treatments and diagnostics for patients. LifeArc’s technology transfer team helps to drive the development of promising science, which includes protecting and managing intellectual property, evaluating the translational potential of research portfolios of our charity partners and advising on funding development paths and routes to market.
About the AUTM Foundation
The Association of University Technology Managers (AUTM) Foundation was created to strengthen and enhance the Association’s efforts to build a better world by advancing academic technology transfer globally. By prompting the transfer of technology from the lab to the marketplace and supporting training for practitioners at all levels, the foundation works to ensure the advancement of the profession.
About AUTM
The Association of University Technology Managers (AUTM) is a non-profit organization that supports the commercialization of academic research innovation through patents, licensing and business development. AUTM’s 3,200 members represent more than 350 universities, research institutions, teaching hospitals, businesses and government organizations around the world.
Record changed: 2023-06-05 |
Advertisement
More documents for LifeArc (GB)
- [1] LifeArc. (5/2/23). "Press Release: Dr Jason Slingsby Joins LifeArc as Chief Business Officer"....
- [2] Maxion Therapeutics Ltd.. (2/15/23). "Press Release: Maxion Therapeutics’ $16 Million Series A to Drive Antibody Development for Previously Untreatable Ion Channel and GPCR-driven Diseases". Cambridge....
- [3] Biocartis Group N.V.. (9/1/20). "Press Release: Biocartis Expands Collaboration with LifeArc". Mechelen & London....
- [4] Kymab Ltd.. (6/24/19). "Press Release: Kymab and LifeArc Enter Strategic Partnership to Discover New Medicines Using Kymab’s IntelliSelect Technologies". Cambridge....
- [5] LifeArc. (5/20/19). "Press Release: LifeArc Monetises Keytruda Royalty Interests to Fund further Research and Investment"....
- [6] LifeArc. (2/27/18). "Press Release: LifeArc Announces £5M Support for Rare Disease Research". London....
- [7] SpringWorks Therapeutics, Inc.. (9/25/17). "Press Release: SpringWorks Therapeutics Launches with $103M in Series A Funding and Rights to Four Clinical Programs". New York, NY....
- [8] LifeArc. (6/15/17). "Press Release: LifeArc Set to Transform Medical Research Landscape"....
- [9] Biocartis Group N.V.. (6/7/17). "Press Release: MRC Technology and Biocartis Initiate Development of Liquid Biopsy Test for Breast Cancer". London & Mechelen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top